Mahmoud M. Farid

Mahmoud M. Farid


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
AAAhmad Abbas
Ahmad Abbas
TATorki Al-Otaibi
Torki Al-Otaibi
OGosama Gheith
osama Gheith
ANAyman Maher Nagib
Ayman Maher Nagib
MFMahmoud M. Farid
Mahmoud M. Farid
MWMohammad Walaa
Mohammad Walaa
COVID-19,medical errors,sleep quality

11 August 2022 in The Egyptian Journal of Bronchology
Verified
Journal Article
Open access
PDF file
TATorki Al-Otaibi
Torki Al-Otaibi
AAAhmad Abbas
Ahmad Abbas
ANAyman Maher Nagib
Ayman Maher Nagib
OGosama Gheith
osama Gheith
PNPrasad Nair
Prasad Nair
MAMohammad A. S. Albader
Mohammad A. S. Albader
Background: Little information is available about the linkage between sleep affection and COVID-19. Preliminary reports and clinical observations focused on the appearance of related mental health issues, especially in healthcare workers (HCWs). Methods: A cross-sectional study is conducted on the COVID-19 second-line HCWs using an English online survey prepared via Google forms. The survey focused on sociodemographic and profession-related characteristics (age, sex, smoking, history of previous sleep disorders or medications affecting sleep, comorbidities specialty, years of experience, and number of hours worked per week) and COVID-19-associated risks (being on the second line of COVID-19 management, following updates and news about COVID-19, and getting an infection with COVID-19 or having a colleague/friend who was infected with or died of COVID-19). Assessment of anxiety, insomnia, and sleep quality was done using the relevant diagnostic scales. Results: This study included 162 second-line HCWs with a mean age of 34.36 ± 8.49 years. Although being in second lines, there was a high prevalence of anxiety (49.38%), insomnia (56.17%), and poor sleep quality (67.9%) during the pandemic. One condition was recently developed after the pandemic: insomnia in 6.6%, anxiety in 5.7%, and poor sleep in 16%. Two conditions were developed: insomnia and poor sleep in 21.7%, anxiety and poor sleep in 7.5%, and insomnia and anxiety in 10.4%. The three conditions were de novo experienced in 19.8%. A total of 22.4% of those who followed daily COVID-19 updates developed de novo combined anxiety, insomnia, and poor sleep. A total of 38.5% of participants that had been infected with COVID-19 developed de novo combined anxiety, insomnia, and poor sleep. A total of 50% of participants who had a colleague/friend who died with COVID-19 developed de novo combined anxiety, insomnia, and poor sleep. Conclusion: Although being in second lines, there was a high prevalence of anxiety, depression, and poor sleep concerning COVID-19-related factors.